Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pilot Study on Evaluating the Geroprotective Effect of Metformin
Sponsor: Xuanwu Hospital, Beijing
Summary
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.
Official title: A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People
Key Details
Gender
MALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
130
Start Date
2024-06-30
Completion Date
2028-07-31
Last Updated
2025-03-21
Healthy Volunteers
Yes
Interventions
Metformin Hydrochloride tablet
Extended release oral tablets, 1000 mg/day, single dose
Placebo
Oral tablets, 1000 mg/day, single dose
Locations (1)
Xuanwu Hospital Capital Medical University
Beijing, China